Conjugated estrogens/norgestrel
Conjugated estrogens/norgestrel (CEEs/NG), sold under the brand name Prempak-C among others, is a combination of conjugated estrogens (CEEs), an estrogen, and norgestrel (NG), a progestin, which is used in menopausal hormone therapy in postmenopausal women.[1][2][3][4] It is taken by mouth and contains 0.625 or 1.25 mg CEEs and 150 μg NG (or 75 μg levonorgestrel) per tablet.[1][2][3][4] The medication is no longer marketed.[5][6]
Combination of | |
---|---|
Conjugated estrogens | Estrogen |
Norgestrel | Progestogen; Progestin |
Clinical data | |
Trade names | Prempak-C |
Other names | CEEs/NG |
Routes of administration | By mouth |
Drug class | Estrogen; Progestin; Progestogen |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number |
References
- Cartwright S, Godlee C (20 January 2012). Churchill's Pocketbook of General Practice E-Book. Elsevier Health Sciences. pp. 55–. ISBN 978-0-7020-5073-2.
- Erkkola R (1 January 2006). The Menopause. Elsevier. pp. 265–. ISBN 978-0-444-51830-9.
- Filshie M, Guillebaud J (22 October 2013). Contraception: Science and Practice. Elsevier Science. pp. 229–. ISBN 978-1-4831-6366-6.
- Constanti A (17 February 1998). Basic Endocrinology for Students of Pharmacy and Allied Health Sciences. CRC Press. pp. 102–. ISBN 978-90-5702-250-0.
- "Norgestrel".
- "Levonorgestrel".
|
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.